Package 31722-203-31

Brand: lacosamide

Generic: lacosamide
NDC Package

Package Facts

Identity

Package NDC 31722-203-31
Digits Only 3172220331
Product NDC 31722-203
Description

10 VIAL, GLASS in 1 CARTON (31722-203-31) / 20 mL in 1 VIAL, GLASS (31722-203-20)

Marketing

Marketing Status
Marketed Since 2022-09-14
Brand lacosamide
Generic lacosamide
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "6708697e-b1a3-4de8-b964-21969afb7834", "openfda": {"nui": ["N0000008486"], "upc": ["0331722203319", "0331722203203"], "unii": ["563KS2PQY5"], "rxcui": ["809974"], "spl_set_id": ["e24d3c45-a559-4fca-a7be-74ce37a7066e"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "manufacturer_name": ["Camber Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "10 VIAL, GLASS in 1 CARTON (31722-203-31)  / 20 mL in 1 VIAL, GLASS (31722-203-20)", "package_ndc": "31722-203-31", "marketing_start_date": "20220914"}], "brand_name": "LACOSAMIDE", "product_id": "31722-203_6708697e-b1a3-4de8-b964-21969afb7834", "dosage_form": "INJECTION", "pharm_class": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "31722-203", "dea_schedule": "CV", "generic_name": "LACOSAMIDE", "labeler_name": "Camber Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "LACOSAMIDE", "active_ingredients": [{"name": "LACOSAMIDE", "strength": "10 mg/mL"}], "application_number": "ANDA216335", "marketing_category": "ANDA", "marketing_start_date": "20220914", "listing_expiration_date": "20261231"}